Your Search Results

EAPCI General Assembly

22 May 2019 – From EuroPCR 2019

Consult this session to discover the EAPCI General Assembly's slides, presented during EuroPCR 2019. Learn more about the different committees and the grants programme.

TAVI for aortic valve-in-valve - LIVE Case

22 May 2019 – From EuroPCR 2019

Consult this session to discover an exciting case, live transmitted during EuroPCR 2019: it will take you to a whole new territory of TAVI, focusing on the generation of bioprosthetic heart valves issues and the transcatheter solutions which are emerging as an optimal approach to this...

Treatment of bending zones in femoral and popliteal arteries - LIVE Case

23 May 2019 – From EuroPCR 2019

Consult this session to learn more about the different characteristics of devices and treatment strategies including: directional atherectomy + drug-coated balloon, calcified plaque softening with lithoplasty, new stents conforming to anatomy, and more!

LIVE demonstration from Clinique Pasteur - Toulouse, France

TAVI in bicuspid aortic stenosis - LIVE Case

23 May 2019 – From EuroPCR 2019

Consult this session to learn more about TAVI in bicuspid aortic stenosis, thanks a LIVE demonstration from St Thomas Hospital - London, United Kingdom, transmitted during EuroPCR 2019. Discover the case of a 84 years-old male with severe symptomatic aortic stenosis in a functionally bicuspid aortic valve; watch...

LAA Closure - LIVE Case

23 May 2019 – From EuroPCR 2019

Consult this session to learn more about how to efficiently manage LAA closure for stroke prevention, thanks to a compelling LIVE demonstration from Institut Cardiovasculaire Paris Sud, France, during EuroPCR 2019. Discover the case of a 81 years-old female with intracranial hemmorrhage and multiple cerebral cavernomatosis; watch the treatment...

RIVER: Rivaroxaban for valvular heart disease and atrial fibrillation

05 Sep 2023

Alex Sticchi provides his take on the results of the RIVER trial, which were presented by Pedro Gabriel Barros E Silva during the ESC 2023 congress in Amsterdam.

Rivaroxaban versus Warfarin in Patients with Bioprosthetic Valves According to Valvular Heart Disease Etiology, and Thrombotic and Bleeding Risks: Insights from...

Author

Alessandro Sticchi

RIVER: Rivaroxaban for valvular heart disease and atrial fibrillation

SURTAVI: five-year results from a randomized trial of TAVR vs. SAVR in patients at intermediate surgical risk

07 Nov 2021

Although TAVI is an accepted alternative to surgery in patients with severe aortic stenosis who are at high surgical risk, less is known about long-term comparative outcomes among patients with aortic stenosis who are at intermediate surgical risk. P. Redaelli & M. Pighi review the SURTAVI trial...